Clinical trial No longer in our active list Interventional Ages 7 and up

Improving design of a new audio processor for cochlear implant users

Official title: Evaluating Design Improvements With SONNET 3 in Experienced Cochlear Implant Users

Run by Med-El Corporation · NCT06597747 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study tests how satisfied experienced cochlear implant users are with a new behind-the-ear audio processor compared to their current one.

Quick facts

Study typeInterventional
Ages7 Years and up
SexAll
Enrollment20 (estimated)
SponsorMed-El Corporation
Industry-sponsored
Locations1 site (Chapel Hill, North Carolina)
Trial IDNCT06597747 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals who have been implanted with a MED-EL cochlear implant for at least 12 months and are currently using a SONNET or SONNET 2 audio processor.

Probably not a fit

Patients with retrocochlear hearing loss or those unable to provide reliable feedback during programming may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective study evaluates user satisfaction with the latest behind-the-ear audio processor model among experienced cochlear implant users. Participants will wear the new MED-EL audio processor and complete a custom questionnaire to compare its design and usability against their current processor. The study employs a single-arm, repeated measures design, allowing participants to serve as their own control. This approach aims to gather direct feedback on the new device's performance and user experience.

Why it matters

Potential benefit: If successful, this study could lead to enhanced audio processing technology that improves the quality of life for individuals with hearing loss.

How similar studies have gone: While this specific approach is novel, similar studies evaluating user satisfaction with audio processors have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Implanted with a MED-EL cochlear implant in at least one ear
* ≥ 12 months since activation of the MED-EL audio processor
* Consistently using a SONNET (EAS) or SONNET 2 (EAS) Audio Processor
* Ability to complete all study procedures
* Participant and parental (if applicable) commitment to comply with all study procedures for the duration of the study

Exclusion Criteria:

* Evidence that hearing loss is retrocochlear in origin
* Unable to provide reliable feedback during cochlear implant programming
* Skin or scalp condition precluding use of the study device
* Unrealistic participant or parent (if applicable) motivation or expectations
* Participants without a stable fitting map at enrollment e.g., due to changes in hearing, global health status, etc.

Where it's running

  • University of North Carolina
    Chapel Hill, North Carolina, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.